Evidence map›Paper›PMID 25659476›Full record

ArticlePsychiatry research2015

A pilot study of gray matter volume changes associated with paroxetine treatment and response in social anxiety disorder.

Ardesheer Talati, Spiro P Pantazatos, Joy Hirsch, Franklin Schneier

Abstract read
In one paragraph

Article in Psychiatry research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. The cerebellum and anxiety.Frontiers in cellular neuroscience · 2023
    Article
  10. Review
  11. Article
  12. Article
  13. Involvement of the cerebellum in migraine.Frontiers in systems neuroscience · 2022
    Review
  14. Review
  15. Article
  16. Molecular and neurocircuitry mechanisms of social avoidance.Cellular and molecular life sciences : CMLS · 2021
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ardesheer TalatiDepartment of Psychiatry, Columbia University Medical Center, New York, NY, USA; Division of Epidemiology, New York State Psychiatric Institute, New York, NY, USA. Electronic address: at2071@columbia.edu.
Spiro P PantazatosDepartment of Psychiatry, Columbia University Medical Center, New York, NY, USA; Division of Molecular Imaging and Neuropathology, New York State Psychiatric Institute, New York, NY, USA.
Joy HirschDepartments of Psychiatry and Neurobiology, Yale School of Medicine, New Haven, CT, USA.
Franklin SchneierDepartment of Psychiatry, Columbia University Medical Center, New York, NY, USA; Division of Clinical Therapeutics, New York State Psychiatric Institute, New York, NY, USA.

Funding

Prenatal Smoke Exposure and Offspring Substance Use: An Imaging-Genetics ApproachK01DA029598 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI TALATI, ARDESHEER · 2010 to 2014
$906k
Neural circuitry of submissive behavior and treatment response in social anxietyR21MH077976 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI SCHNEIER, FRANKLIN R. · 2007 to 2008
$355k
Pattern analysis of large-scale functional connectivity to predict implicit emotiF31MH088104 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PANTAZATOS, SPIRO PETER · 2010 to 2012
$112k
NIDA NIH HHS 1K01DA029598NIDA NIH HHS K01 DA029598NIMH NIH HHS F31 MH088104NIMH NIH HHS F31MH088104-02NIMH NIH HHS R21 MH077976NIMH NIH HHS R21MH077976
6 · The paper itself

Abstract

Social anxiety disorder (SAD) has received relatively little attention in neurobiological studies. We sought to identify neuro-anatomical changes associated with successful treatment for the disorder. Fourteen patients (31 years; 57% female) with DSM-IV generalized SAD were imaged before and after 8-weeks of paroxetine treatment on a 1.5 T GE Signa MRI scanner. Symptoms were assessed by a clinician using the Liebowitz Social Anxiety Scale (LSAS). Longitudinal changes in voxel based morphometry (VBM) were determined using the VBM8 Toolbox for SPM8. Symptom severity decreased by 46% following treatment (p<0.001). At week 8, significant gray matter reductions were detected in bilateral caudate and putamen, and right thalamus, and increases in the cerebellum. Gray matter decreases in left thalamus were correlated with clinical response. This is the first study to our knowledge to identify treatment related correlates of symptom improvement for SAD. Replication in larger samples with control groups is needed to confirm these findings, as well as to test their specificity and temporal stability.

Indexed as

AdultFemaleGray MatterHumansMagnetic Resonance ImagingMaleParoxetinePhobic DisordersPilot ProjectsSelective Serotonin Reuptake InhibitorsTreatment OutcomeParoxetineSelective Serotonin Reuptake InhibitorsCaudateCerebellumParoxetineSocial anxietyStructural MRIThalamus

Identifiers

PMID25659476
PMCPMC4363180

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.